3

FORM 3 SUBMISSION

Company: Arcutis Biotherapeutics, Inc.
Filed: January 30, 2020
Period of Report: January 30, 2020
Accession Number: 0001209191-20-005690

View Document ↗ View on SEC.gov ↗